Download - Chemotherapeutic Agents or Anti-Microbials
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
1/36
Introduction toAntimicrobial Agents
Dr. SalmanKhan
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
2/36
Chemotherapeutic Agents OR
Anti-microbials Some Definitions:
Anti-Biotics: These are chemical substancesproduced by various species of micro-organisms ( bacteria, fungi, actenomycetes)that suppress the growth of other micro-
organisms and may eventually destroy them.(antibacterials, antivirals, anti-fungals)
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
3/36
Chemotherapeutic Agents OR
Anti-microbials Important consideration: Common
usage often extends the term
antibiotics to include syntheticantibacterial agents, such assulfonamides, quinolones, that are notproducts of microbes (Goodman & Gillman)
BUT: we will call them anti-bacterials ORantimicrobials OR Chemotherapeuticagents derived from non-living things
OR synthetically produced.
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
4/36
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
5/36
Beta-lactamases: Bacterial enzymes( penicillinase, cephalosporinase) thathydrolyze the beta lactam ring of certain
penicillins and cephalosporins. Minimal Inhibitory concentration: lowest
concentration of antimicrobial drug capable ofinhibiting growth of an organism in a definedgrowth medium. (MIC)
Penicillin binding Proteins: Bacterialcytoplasmic membrane proteins that act asthe initial receptors for penicillins and other
beta-lactam antibiotics. (PBPs)
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
6/36
Peptidoglycan, murein: Chains ofpolysaccharides and polypeptides that are
cross linked to form bacterial cell wall. Selective toxicity: More toxic to the invader
than to the host; a property of usefulantimicrobials.
Transpeptidases: bacterial enzymesinvolved in the cross-linking of linearPeptidoglycan chains, the final step in cell wallsynthesis.
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
7/36
Targets for AntimicrobialDrugs that Bind to the30S bacterial ribosomalsubunit, leading to cell
death
Agents that interferewith nucleic acidsynthesis
Antimetabolites
Bacterial Cell WallSynthesis Inhibitors
Protein SynthesisInhibitors: interfere with30S or 50S bacterialribosome function
Agents that Increase Cell
Membrane Permeability
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
8/36
Agents that increase cellmembrane permeability:polymixins (detergent)
colistimethate (detergent)
nystatin (Mycostatin)(polyene antifungal)
amphotericin B (polyene antifungal)
Antimetabolites sulfonamides
trimethoprim (generic)
Agents that interfere with nucleicacid synthesis:
rifamycins (rifampin (Rimactane)):inhibits DNA-dependent RNApolymerase
quinolones: inhibit gyrase
Drugs that bind to the 30Sbacterial ribosomal subunit,leading to cell death.
Bactericidal
Aminoglycosides (e.g.gentamicin(Garamycin), tobramycin (Nebcin))
Protein synthesis inhibitors: interferewith 30S or 50S bacterial ribosomefunction.
Bacteriostatic
chloramphenicol (Chloromycetin)
tetracyclineserythromycin
clindamycin
Bacterial cell wall synthesisinhibitors:
penicillins
cephalosporins
cycloserine
vancomycin (Vancocin)
bacitracin
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
9/36
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
10/36
Bactericidal agentsAminoglycosides, bacitracin, beta-lactamantibiotics, isoniazid, metronidazole,polymyxins, pyrazinamide, quinolones,rifampin, vancomycin [Lampris & Maddix
98,p818 and Katzung8th2001p860] Bacteriostatic agents Chloramphenicol, clindamycin, ethambutol,
macrolides, nitrofurantoin, novobiocin,oxazolidinones, sulfonamides, tetracyclines,trimethoprim [Lampris & Maddix 98,p818 and
Katzung8th2001p860]
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
11/36
Spectra of Anti-microbials The clinical SPECTRUM of organisms is indicated by various
terms. BROAD SPECTRUM includes drugs like the tetracyclinesthat have no strong predilection for gram positive or gramnegative organisms and may even act against such organisms
as Rickettsia or even protozoans. Few of the broad spectrumantimicrobials affect such a wide range of organisms.NARROW SPECTRUM Drugs, such as penicillin G, are primarilyactive against GRAM POSITIVE organisms. Gentamicin is anexample of a drug that is especially used to treat infections byGRAM NEGATIVE organisms. Some drugs have such a specialclinical niche that they are commonly referred to as a memberof that niche despite the fact that they do have other actions. The PENICILLINASE resistant penicillins (e.g., methicillin) andEXTENDED SPECTRUM penicillins (e.g., ticarcillin) areexamples. It is important to note that classifications based onspectrum do not imply that a drug will be active against allorganisms in the class. Some organisms are notorious for the
unpredictability of their response to an antimicrobial whereasothers are highly predictable.
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
12/36
Combination Therapy Combination chemotherapy may be
warranted to: Decrease the likelihood of emergence of
resistant mutants. A single agent will beeffective against sensitive organisms, but notagainst those that have developed a mutated"target" site, which is no longer susceptible orhas diminished susceptibility to the drug. Inthis case the single drug will select out themutant, resistant strain. This effect is morelikely when the concentration of theantibacterial agent approximates the MIC(minimum inhibitory concentration).
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
13/36
A second agent, which acts by a differentmechanism, may prevent the emergence ofthe resistant strain (e.g. impenem +aminoglycoside for systemic Pseudomonas).
To take advantage of additive/synergisticaction against some bacteria. Combination oftrimethoprim-sulfamethoxazole (Septran) is
effective against many enteric gram negativebacteria. And the combination becomesbactericidal.
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
14/36
Advantages of combinations Some combinations frequently synergistic
trimethoprim plus sulfonamide Enterococcal endocarditis with penicillin and
streptomycin Cryptococcal meningitis with amphotericin B
plus flucytosine Mixed infections
Decrease development of resistant organismsas in treatment of tuberculosis with isoniazidplus pyrazinamide and rifampin
Serious, life-threatening infections of unknownorigin or in sepsis or meningitis
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
15/36
Disadvantages of combinations
Interference with action of cidalantibiotic that depends on rapid growth
by a static antibiotic that inhibits growth Increased risk of toxicity to patient
Increased cost
Increased risk of development ofresistant organisms in patient orpopulation by use of antibacterials nottruly needed
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
16/36
Mechanisms for chemotherapeuticdrugs resistance
Bacterial resistance may occur because the drugdoes not reach its target site, drug is inactivated,or there is some sort of molecular alteration in
the target itself, possibly due to mutation. Resistance may occur because enzymes at or near the
cell surface inactivate the antibiotic; the cell membraneis impermeable to the drug; there is an absence ofaqueous channels (porins) through which the drug will
reach the cell interior; there is a lack of a necessarytransport system to support drug translocation; thetransport mechanism is present but inoperative due toanaerobic metabolism; there are target site changesthat results in reduced or absent antibacterial drugefficacy.
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
17/36
How Bacteria Acquire
Resistance Resistance may be acquired by vertical transfer,
i.e. acquired by mutation and then passed to daughtercell
Mutations: Specific genetic mutations are themolecular basis for resistance to streptomycin(ribosomal mutation), to quinolones (DNA gyrase genemutation) and to rifampin (Rimactane) (RNA polymerasegene mutation)
o The mutation to rifampin is an example of a single-stepmutation: In this case E. coli or Staph. aureus exposureto rifampin results in highly resistant strain due to apoint mutation in the RNA polymerase gene such thatthe polymerase protein no longer binds rifampin
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
18/36
More usually, acquired by horizontal transfer ofresistance factors from a donor cell, perhaps of adifferent species by transformation whichinvolves the incorporation of DNA found free
environment into the bacterial genomeo An example of this process is the basis of penicillin
resistance in. pneumococci and Neisseria gonorrhea. Penicillin-resistant pneumococci produce different PBPs
(penicillin-binding proteins). These different PBPs
exhibit relatively low affinity for penicillin compared towild type pneumococci. These different PBPs arise from integration of foreign
DNA which were most likely from a closely relatedstreptococcal strain into the PBP gene by a process ofhomologous recombination
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
19/36
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
20/36
Transduction-based resistance occurs when abacteriophage which includes bacterial DNA in itsprotein coat infects the bacteria. This bacterial DNA may
contain a gene confiring resistance to antibacterialdrugs.
Examples of this process:
Staphylococcus aureus strain resistance development topenicillin may occur by transduction (Some
bacteriophages carry plasmids [extrachromosomal self-replicating DNA] that code for penicillinase
Other phages can transfer genes which conferresistance to tetracycline (Achromycin), erythromycinestolate (Ilosone), and chloramphenicol
(Chloromycetin).
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
21/36
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
22/36
Conjugation is another important mechanism forsingle and multi-drug resistance development. Inconjugation direct passage of resistance-conferring DNA between bacteria proceeds by
way of a bridgeo The genetic material transfer in conjugation
requires two elements: an R-determinantplasmid which codes for the resistance and aresistance-transfer factor (RTF) plasmid whichcontains the genes necessary for the bacterialconjugation process. Occasionally twoplasmids join to form a complete R factor
o Some genes that are responsible for resistance
are located on transposons which can movefrom location to location within lasmid and
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
23/36
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
24/36
Conjugation mediated resistance is particularlyimportant in gram-negative bacilli.
o Enterococci may contain plasmids that spreadresistance among gram-positive organisms
Vancomycin (Vancocin) resistance in enterococcalstrains appears to occur as a result of the conjugationmechanism.
Conjugation is not a high efficiency mechanism forresistance development. Unfortunately, antibiotic use
provides selection pressures which facilitate theelaboration of resistance bacteria. Furthermore, entericbacteria carrying plasmids for multidrug resistance isnow a worldwide, serious concern.
Resistance acquired by horizontal transfer candisseminate rapidly through the bacterial population by
clonal spread as well as by continuing genetic material
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
25/36
Complications Of Anti-biotic therapy Adverse Effects
Adverse effects of antimicrobials
may be divided into three broadcategories:
Allergic
Biological
Toxic
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
26/36
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
27/36
Biological Adverse Effects of
Antimicrobials More likely
Broad spectrum drugs Alteration of normal flora Skin Mucous membranes Gastrointestinal tract Reproductive tract Likely pathogens yeasts Clostridium difficile Superinfection / Suprainfection
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
28/36
Antibiotic Associated Enterocolitis ACCESS!!
ampicillin, tetracyclines, LINCOMYCIN, andother broad spectrum antibacterials
spectrum -- broad, effective against anaerobes
Antibiotic Associated Pseudomembranous
Enterocolitis Associated with overgrowth ofClostridium
difficile
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
29/36
Direct Toxic Effects ofAntibacterials
Life threateningo Liver failure -- isoniazido Respiratory paralysis -- neuromuscular paralysis --
aminoglycosides Severeo Hearing loss (ototoxicity)-- aminoglycosideso Nephrotoxicosis -- proximal tubular cells --
aminoglycosideso Nephrotoxicosis -- tubular crystal formation --
Sulfonamideso Decreased immune function -- many
antibiotics
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
30/36
o Bone / tooth malformation due to binding tocalcium -- tetracyclines
o Antibody production inhibited by --amphotericin B, cefoxitin, doxycycline,rifampin, cefotaxime, chloramphenicol,moxalactam, and trimethoprim-sulfamethoxazole.
o Microbiocidal activity impaired by -- amikacin,cephalothin, gentamicin, sulfonamides,tetracycline, and tobramycin
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
31/36
Unpleasanto Mild abdominal discomfort / pain --
erythromycino Dizziness -- minocycline
o Mild vomiting
o Loose stools to mild diarrheao Tooth discoloration -- tetracyclines
A i t d I i t
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
32/36
Appropriate and InappropriateUses of Chemotherapy
Appropriate Use Before the organism is identified: either
combination therapy or a single broad
spectrum agent may be used. After the organism is identified, a low-toxicity
regimen with a narrow-spectrum drug isindicated.
Selection of the drug should be governed byits selectivity for the most likely involvedbacteria and its toxicity.
First decide if an antibiotic is indicated sinceantibiotics may be toxic. Inappropriate use
may hinder diagnosis, and can result in
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
33/36
Some Clinical Issues
Optimal empirical treatment requires knowledge ofthe antibiotic sensitivity of the organisms which ismost likely causing the infection.
Assessment with Gram's stain and other tests mustbe used to narrow the list of pathogens.
In life threatening situations, the selection of asingle narrow-spectrum agent may not be possibleand broad coverage would be indicated until a
definitive identification is possible.
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
34/36
Inappropriate Uses
Treatment of Untreatable Infections The infection is viral. Antimicrobial treatment of measles, mumps and 90% of
upper respiratory infections are inappropriate. Treatment of fever of unknown origin: Antimicrobials are not antipyretic agents. Pyrexia of short duration, without localizing signs, is
most likely due to viral infection. Three infections may be associated with
prolonged fever: tuberculosis hidden intra-abdominal abscesses infective endocarditis. other causes: cancer, metabolic disorders, hepatitis,
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
35/36
Improper dosage: Some drugs, such as the aminoglycosides, are frequently
administered at subtherapeutic dosages because of concern
about toxicity. Clinical treatment failure and selection of resistant strains may
result. Inappropriate Dependence on Chemotherapy
Alone:
Some disorders require both chemotherapy and asurgical procedure, especially if significant amount ofnecrotic tissue is present.
Example : Pneumonia in a patient with empyema(accumulation of pus) may be effectively manage
following drainage
-
8/14/2019 Chemotherapeutic Agents or Anti-Microbials
36/36
Lack of Adequate Bacteriological Information:
About one-half of antimicrobial therapy is given tohospitalized patients without support frommicrobiological data. [clinical judgment alone];
Antimicrobial therapy must be individualized, notadministered based on prescribing habit alone